Veeva CFO Equity Grant: 872 RSUs, Tax Withholding of 274 Shares
Rhea-AI Filing Summary
Brian Van Wagener, Chief Financial Officer of Veeva Systems Inc. (VEEV), reported equity transactions on 10/01/2025. He received 872 restricted stock units (RSUs) that convert one-for-one to Class A common shares and were recorded with a $0 per-share acquisition price because they are grants. The filing shows 274 shares were withheld by the issuer to satisfy tax-withholding obligations at an indicated price of $293.26 per share, reducing his post-transaction direct holdings to 7,331 shares. Following the RSU grant, he beneficially owns 7,605 shares before the withholding. The RSUs vest under the company’s Amended & Restated 2013 Equity Incentive Plan with 25% vesting on July 1, 2025 and the remainder vesting quarterly over the following year, subject to continued service.
Positive
- 872 RSU grant aligns CFO incentives with shareholders through time-based vesting
- Vesting schedule (25% then quarterly) promotes retention over the next year
- Transactions exempt under Rule 16b-6(b) and Rule 16b-3(e), indicating standard compliance
Negative
- None.
Insights
Insider received 872 RSUs; 274 shares withheld for taxes at $293.26.
This Form 4 discloses a routine equity award and tax withholding rather than an open-market sale. The grant of 872 RSUs increases long-term alignment with shareholders because RSUs vest over time under the issuer’s 2013 Equity Incentive Plan. The withholding of 274 shares to cover taxes is a common administrative step and is reported as an internal remittance rather than a market disposition.
Vesting schedule: 25% on July 1, 2025, then quarterly over one year.
The RSU vesting—25% upfront then quarterly—means the executive’s ownership increases incrementally, tying retention to continued service. The filing confirms the award is governed by the company’s equity plan; no exercise price applies because these are RSUs. The transactions are exempt under Rule 16b-6(b) and Rule 16b-3(e), indicating typical Section 16 compliance for grants and tax withholdings.
FAQ
What did VEEV CFO Brian Van Wagener transact on 10/01/2025?
How many VEEV shares does the reporting person own after the transactions?
What is the vesting schedule for the RSUs granted to the CFO?
Were these transactions market sales or grants?
Are these transactions subject to Section 16 reporting exemptions?